Clinical Trial Update: Safety and Feasibility of Dasatinib and Quercetin in Adults at Risk for Alzheimer's Disease [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study assessing safety and feasibility of dasatinib (Sprycel) in combination with quercetin in adults at risk for Alzheimer's disease; the trial is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Quercetin (quercetin)
• Sprycel (dasatinib)

Snippet

Sponsor: Lewis Lipsitz | Conditions: Aging | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-03-17